drugset / Trial / NCT01971346
The Immunological Basis for Treatment Resistance to Anti-TNF Treatments
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine the relationship between two types of cell signals, type I interferon (IFN) and tumor necrosis factor (TNF), in psoriatic skin prior to and during treatment with etanercept and correlate that information with the degree of the improvement in the psoriasis.
Timeline
- Start
- 2014-03-13
- Primary completion
- 2017-11-01
- Completion
- 2017-11-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Etanercept | Protein / enzyme biologic | 100 mg | Subcutaneous |